Japan's most-admired pharmaceutical companies in 2008 - by P Reed Maurer

16 February 2009

International Alliances Limited has conducted annual surveys since 1999 to determine Japan's most-admired pharmaceutical companies. The latest (the 10th that has been published) was conducted in November of 2008. The full report, available from IAL for 30,000 yen (about $333), analyzes responses by each category of responders, overall replies, and trends over time.

30companies, 15 Japanese, and 15 foreign affiliates were evaluated. They included:

Japanese

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight